» Authors » Erol Tulumen

Erol Tulumen

Explore the profile of Erol Tulumen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 462
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozdemir I, Sincer Y, Yaylak D, Aygun E, Tulumen E, Senturk E
A A Pract . 2024 Nov; 18(11):e01865. PMID: 39513625
Takotsubo cardiomyopathy (TCM) is a reversible condition characterized by apical ballooning of the left ventricle, primarily triggered by catecholamine discharge due to stress. Patients may present with symptoms similar to...
2.
Ansari U, Overhoff D, Burkhoff D, Fastner C, Yucel G, Roger S, et al.
Sci Rep . 2022 Nov; 12(1):20504. PMID: 36443407
We hypothesized that myocardial septal scarring, assessed by cardiac magnetic resonance (CMR) using late gadolinium enhancement (LGE), at the site of cardiac contractility modulation (CCM) lead placement may predict treatment...
3.
Gauter-Fleckenstein B, Tulumen E, Rudic B, Borggrefe M, Polednik M, Fleckenstein J
Strahlenther Onkol . 2022 Mar; 198(6):566-572. PMID: 35267050
Purpose: In the beam penumbra of stereotactic body radiotherapy volumes, dose rate effects in implantable cardioverter-defibrillators (ICDs) may be the predominant cause for failures in the absence of neutron-generating photon...
4.
Demir S, Gulsen K, Kepez A, Uslu A, Kup A, Celik M, et al.
J Electrocardiol . 2021 Dec; 70:50-55. PMID: 34922221
Background: The aim of the present study is to investigate the possible factors that might be predictive of effective antiarrhythmic effect of beta-blockers on premature ventricular complexes (PVC). Methods: Data...
5.
Overhoff D, Ansari U, Hohneck A, Tulumen E, Rudic B, Kuschyk J, et al.
ESC Heart Fail . 2021 Nov; 9(1):574-584. PMID: 34818694
Aims: The aim of this study was to evaluate the prognostic value of feature tracking (FT) derived cardiac magnetic resonance (CMR) strain parameters of the left ventricle (LV)/right ventricle (RV)...
6.
Hohneck A, Overhoff D, Rutsch M, Rudic B, Tulumen E, Wolpert C, et al.
Hellenic J Cardiol . 2021 Jun; 62(5):329-338. PMID: 34082115
Objective: This study evaluated the prognostic significance of cardiac magnetic resonance myocardial feature tracking (CMR-FT) in patients with Brugada syndrome (BrS) to detect subclinical alterations and predict major adverse events...
7.
Tulumen E, Rudic B, Ringlage H, Hohneck A, Roger S, Liebe V, et al.
Heart Rhythm . 2021 Jan; 18(6):954-961. PMID: 33515714
Background: Only a minority of patients who receive an implantable cardioverter-defibrillator (ICD) on the basis of left ventricular ejection fraction receive appropriate ICD therapy. Peri-infarct scar zone assessed by late...
8.
Boda-Heggemann J, Blanck O, Mehrhof F, Ernst F, Buergy D, Fleckenstein J, et al.
Int J Radiat Oncol Biol Phys . 2021 Jan; 110(3):745-756. PMID: 33508373
Purpose: Cardiac radioablation is a novel treatment option for therapy-refractory ventricular tachycardia (VT) ineligible for catheter ablation. Three-dimensional clinical target volume (CTV) definition is a key step, and this complex...
9.
10.
Kuschyk J, Muller-Leisse J, Duncker D, Tulumen E, Fastenrath F, Fastner C, et al.
Int J Cardiol . 2020 Sep; 323:100-105. PMID: 32871189
Background: Inherited arrhythmia syndromes and genetic cardiomyopathies attribute in a significant proportion to sudden cardiac death. Implantable cardioverter defibrillators (ICDs) are the cornerstone in the prevention of sudden death in...